levothyroxine / liothyronine Oral Product
- RxCUI
- 1602751
- RxNorm name
- levothyroxine / liothyronine Oral Product
- Term type
- SCDG
- Status
- Active
- Updated
- 2026-11-02 22:13:56
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 032015
- Active start
- 032015
- Multiple ingredient
- YES
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| levothyroxine | 10582 |
| liothyronine | 10814 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | levothyroxine / liothyronine Oral Product | 1 | NAMES |
| RxNorm Name | levothyroxine / liothyronine Oral Product | 1 | NAMES |
| TTY | SCDG | 1 | ATTRIBUTES |
| RxCUI | 1602751 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | H03AA | Thyroid hormones | ATC1-4 | levothyroxine sodium | |
| ATC | H03AA | Thyroid hormones | ATC1-4 | liothyronine sodium | |
| FDASPL | D013974 | Thyroxine | CHEM | has_chemical_structure | levothyroxine |
| FDASPL | D014284 | Triiodothyronine | CHEM | has_chemical_structure | liothyronine |
| FDASPL | N0000175945 | l-Thyroxine | EPC | has_epc | levothyroxine |
| FDASPL | N0000175946 | l-Triiodothyronine | EPC | has_epc | liothyronine |
| MEDRT | D013974 | Thyroxine | CHEM | has_ingredient | levothyroxine sodium |
| MEDRT | D013974 | Thyroxine | CHEM | has_ingredient | levothyroxine |
| MEDRT | D014284 | Triiodothyronine | CHEM | has_ingredient | liothyronine sodium |
| MEDRT | D014284 | Triiodothyronine | CHEM | has_ingredient | liothyronine |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | ci_with | liothyronine sodium |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | ci_with | liothyronine |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | ci_with | levothyroxine sodium |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | ci_with | levothyroxine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | levothyroxine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | liothyronine sodium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | liothyronine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | levothyroxine sodium |
| MEDRT | D006042 | Goiter | DISEASE | may_treat | liothyronine sodium |
| MEDRT | D006042 | Goiter | DISEASE | may_prevent | liothyronine |
| MEDRT | D006042 | Goiter | DISEASE | may_treat | liothyronine |
| MEDRT | D006042 | Goiter | DISEASE | may_treat | levothyroxine sodium |
| MEDRT | D006042 | Goiter | DISEASE | may_prevent | liothyronine sodium |
| MEDRT | D006042 | Goiter | DISEASE | may_treat | levothyroxine |
| MEDRT | D007037 | Hypothyroidism | DISEASE | may_prevent | liothyronine sodium |
| MEDRT | D007037 | Hypothyroidism | DISEASE | may_prevent | levothyroxine sodium |
| MEDRT | D007037 | Hypothyroidism | DISEASE | may_prevent | levothyroxine |
| MEDRT | D007037 | Hypothyroidism | DISEASE | may_prevent | liothyronine |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | levothyroxine sodium |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | levothyroxine |
| MEDRT | D009230 | Myxedema | DISEASE | may_treat | liothyronine sodium |
| MEDRT | D009230 | Myxedema | DISEASE | may_treat | levothyroxine |
| MEDRT | D009230 | Myxedema | DISEASE | may_treat | levothyroxine sodium |
| MEDRT | D009230 | Myxedema | DISEASE | may_treat | liothyronine |
| MEDRT | D013959 | Thyroid Diseases | DISEASE | may_diagnose | levothyroxine sodium |
| MEDRT | D013959 | Thyroid Diseases | DISEASE | may_diagnose | liothyronine sodium |
| MEDRT | D013959 | Thyroid Diseases | DISEASE | may_diagnose | liothyronine |
| MEDRT | D013959 | Thyroid Diseases | DISEASE | may_diagnose | levothyroxine |
| MEDRT | D013964 | Thyroid Neoplasms | DISEASE | may_treat | levothyroxine |
| MEDRT | D013964 | Thyroid Neoplasms | DISEASE | may_treat | liothyronine sodium |
| MEDRT | D013964 | Thyroid Neoplasms | DISEASE | may_treat | levothyroxine sodium |
| MEDRT | D013964 | Thyroid Neoplasms | DISEASE | may_treat | liothyronine |
| MEDRT | D013967 | Thyroiditis, Autoimmune | DISEASE | may_treat | levothyroxine |
| MEDRT | D013967 | Thyroiditis, Autoimmune | DISEASE | may_treat | levothyroxine sodium |
| MEDRT | D013967 | Thyroiditis, Autoimmune | DISEASE | may_treat | liothyronine |
| MEDRT | D013967 | Thyroiditis, Autoimmune | DISEASE | may_treat | liothyronine sodium |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | ci_with | levothyroxine sodium |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | may_treat | levothyroxine sodium |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | may_treat | liothyronine sodium |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | ci_with | liothyronine sodium |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | ci_with | levothyroxine |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | may_treat | levothyroxine |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | may_treat | liothyronine |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | ci_with | liothyronine |
| MEDRT | N0000000237 | Thyroid Hormone Receptor Agonists | MOA | has_moa | liothyronine sodium |
| MEDRT | N0000000237 | Thyroid Hormone Receptor Agonists | MOA | has_moa | levothyroxine sodium |
| MEDRT | N0000000237 | Thyroid Hormone Receptor Agonists | MOA | has_moa | liothyronine |
| MEDRT | N0000000237 | Thyroid Hormone Receptor Agonists | MOA | has_moa | levothyroxine |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | liothyronine sodium |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | levothyroxine sodium |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | liothyronine |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | levothyroxine |
| MEDRT | N0000009340 | Increased Gluconeogenesis | PE | has_pe | levothyroxine sodium |
| MEDRT | N0000009340 | Increased Gluconeogenesis | PE | has_pe | levothyroxine |
| MEDRT | N0000009340 | Increased Gluconeogenesis | PE | has_pe | liothyronine sodium |
| MEDRT | N0000009340 | Increased Gluconeogenesis | PE | has_pe | liothyronine |
| MEDRT | N0000009399 | Increased Metabolic Rate | PE | has_pe | liothyronine sodium |
| MEDRT | N0000009399 | Increased Metabolic Rate | PE | has_pe | liothyronine |
| MEDRT | N0000009399 | Increased Metabolic Rate | PE | has_pe | levothyroxine |
| MEDRT | N0000009399 | Increased Metabolic Rate | PE | has_pe | levothyroxine sodium |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.025 MG / 0.00625 MG (expressed as liothyronine sodium) |
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.1 MG / 0.025 MG (expressed as liothyronine sodium) |
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.15 MG / 0.0375 MG (expressed as liothyronine sodium) |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | SNOMEDCT | 768535008 |
| SOURCES | Source | US Edition of SNOMED_CT |